https://www.pharmaceutical-technology.com/uncategorized/newsgeneric-drug-makers-lundbeck-and-ranbaxy-face-eu-pay-for-delay-fine/ 2013-06-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremay-stories-human-cloning-breakthrough-ranbaxy-record-fine/ 2013-06-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsextended-use-of-tamoxifen-halved-breast-cancer-recurrence-risk-study/ 2013-06-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsks-kidney-cancer-drug-delays-ovarian-cancer-relapse/ 2013-06-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscottish-scientists-to-conduct-first-human-trials-on-synthetic-blood/ 2013-05-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayers-amd-drug-to-rival-lucentis-after-nice-recommendation/ 2013-05-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-two-drugs-for-late-stage-melanoma/ 2013-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-to-acquire-vaccine-technology-company-okairos/ 2013-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvaccine-protects-chinese-children-against-hand-foot-and-mouth-disease/ 2022-10-10T12:41:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgileads-4-in-1-hiv-pill-wins-european-approval/ 2013-05-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-drug-may-reduce-tissue-damage-after-a-heart-attack/ 2013-05-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvaleant-to-acquire-global-eye-care-firm-for-87bn/ 2023-03-20T15:33:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstsri-develops-new-technique-for-finding-therapeutic-antibodies/ 2013-05-24T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsstatins-may-increase-risk-diabetes-risk-study/ 2013-05-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-step-closer-to-developing-universal-influenza-jab/ 2013-05-23T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-responds-to-fda-warning-letter/ 2013-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsactavis-to-acquire-warner-chilcott-in-85-billion-deal/ 2013-05-22T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsalzheimers-drug-trial-coincides-with-uks-dementia-awareness-week/ 2013-05-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-scientists-hail-brain-disease-breakthrough/ 2013-05-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsranbaxy-laboratories-gets-tentative-approval-for-hiv-combination-therapy/ 2013-05-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayer-acquires-herbal-medicines-manufacturer/ 2013-05-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newselan-strikes-two-more-drug-deals-to-fend-off-royalty-pharma-bid/ 2013-05-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-firm-halts-sale-of-convulsion-drug-to-arkansas-over-death-row-use/ 2013-05-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-radiation-prostate-cancer-drug/ 2013-05-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-releases-positive-results-for-first-of-its-kind-leukaemia-drug/ 2013-05-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-human-cloning-breakthrough-turns-skin-cells-into-embryos/ 2013-05-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureanimal-antibiotic-resistance-food-human-health/ 2013-05-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslow-cost-rotavirus-vaccine-revealed-by-scientists-in-india/ 2013-05-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshuman-rights-watch-welcomes-ukraines-palliative-care-breakthrough/ 2013-05-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseli-lilly-phase-iii-lymphoma-study-fails-to-meet-primary-endpoint/ 2013-05-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsranbaxy-pays-record-fine-in-adulterated-drugs-case/ 2013-05-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-wins-approval-for-copd-drug/ 2013-05-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdeadly-coronavirus-may-be-able-to-spread-from-person-to-person-say-who/ 2013-05-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-and-save-the-children-partner-to-save-one-million-lives/ 2013-05-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbacteria-makes-mosquitoes-resistant-to-malaria-study/ 2013-05-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsspider-venom-vaccine-a-future-possibility-due-to-new-research/ 2021-10-25T12:57:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsshire-signs-rare-disease-discovery-deal-with-nimbus/ 2013-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureprescribing-placebos-uk-doctors-fake-drugs/ 2013-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-to-cell-viagra-online-to-combat-sales-of-fake-pills/ 2013-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscottish-cancer-drug-fund-rejected-by-experts/ 2013-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-warns-against-taking-valproate-products-for-migraines-during-pregnancy/ 2013-05-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaesica-university-of-nottingham-to-develop-novel-drug-synthesis-method/ 2013-05-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuresofrigam-cool-packaging-pharmaceuticals-save-lives/ 2017-10-26T11:45:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsteva-pharmaceutical-first-quarter-profits-fall-27/ 2013-05-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsallegro-senju-to-develop-therapy-for-blinding-diseases-in-japan/ 2013-05-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsflu-shingles-and-diarrhoea-jabs-added-to-uk-immunisation-programme/ 2013-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfirst-h7n9-avian-influenza-vaccine-developed/ 2013-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureapril-stories-roche-tamiflu-data-novartis-patent-rejected-india/ 2013-04-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsswedish-scientists-unveil-sugars-transport-link-to-cancer-cells/ 2013-04-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-prescription-free-emergency-contraception-for-15-year-olds/ 2013-04-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsclinical-trial-starts-in-the-uk-to-heal-hearts-with-genetic-virus/ 2023-01-24T16:05:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-kcentra-to-reverse-severe-effects-of-anticoagulation/ 2013-04-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-identify-artemisinin-resistant-malaria-strains-in-cambodia/ 2013-04-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstakeda-ordered-to-pay-patient-65m-over-actos-drug-cancer-risk/ 2013-04-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscancer-could-overwhelm-latin-america-say-experts/ 2013-04-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsspecialists-urge-pharma-companies-to-reduce-cancer-treatment-cost/ 2013-04-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-acts-against-counterfeit-malaria-drugs-with-new-partnership/ 2013-04-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-sued-by-us-over-kidney-drug-kickback/ 2013-04-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-directions-joins-irx-reminder-to-develop-smartphone-technology-for-clinical-trials/ 2013-04-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-hiv-spread-could-be-halted-within-a-generation-says-new-government-campaign/ 2013-04-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurenewcastle-disease-cancer-killing-avian-virus/ 2013-04-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-partners-with-avalon-ventures-in-495m-deal/ 2013-04-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspatient-cancer-treatment-could-be-determined-by-computer-in-near-future/ 2013-04-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-accused-of-delaying-seroxat-generics-from-entering-uk-market/ 2013-04-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofis-6-in-1-paediatric-vaccine-approved-by-european-commission/ 2013-04-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamgen-settles-kickback-allegations-with-249-million-settlement/ 2013-04-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsimpel-neuropharma-completes-first-ever-nose-to-brain-delivery-study/ 2013-04-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-22/ 2023-04-12T06:29:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshikma-group-keeps-hold-of-injectables-after-review/ 2013-04-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnanostring-secures-worldwide-license-for-liver-cancer-gene-signature/ 2013-04-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-to-assess-human-impact-of-antibiotics-used-in-animals/ 2013-04-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-supreme-court-hears-human-genome-patent-case/ 2013-04-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurenoble-intentions-eu-falsified-medicines-directive/ 2013-04-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-grant-marketing-authorisation-for-bioalliances-herpes-treatment/ 2013-04-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroyalty-pharma-increases-takeover-bid-for-elan/ 2013-04-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-sub-type-of-bowl-cancer-discovered/ 2013-04-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-foundation-to-investigate-compound-in-fatal-childhood-disease/ 2013-04-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsobjective-way-to-measure-pain-discovered/ 2013-04-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofi-to-produce-tons-of-synthetic-antimilarial-drugs/ 2013-04-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-to-fast-track-pfizers-breast-cancer-drug/ 2013-04-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdksh-to-provide-services-for-pfizer-in-cambodia/ 2013-04-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgenentech-experimental-cancer-drug-shows-positive-results-in-phase-i-study/ 2013-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseu-funded-partnership-targets-kinases-to-develop-anti-cancer-drugs/ 2013-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsprostate-cancer-patients-with-faulty-brca2-need-urgent-treatment-study/ 2013-04-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfirst-mutations-of-child-leukaemia-traced-back-to-the-womb/ 2013-04-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-combination-therapy-cures-patient-with-advanced-ovarian-cancer/ 2013-04-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmore-failures-uncovered-at-us-compounding-centres/ 2023-06-30T06:09:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-provides-access-to-tamiflu-data-after-three-year-delay/ 2013-04-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-discover-new-genetic-marker-for-alzheimers-disease/ 2013-04-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshiv-vaccine-hope-after-scientists-track-immune-systems-response-to-virus-in-the-body/ 2022-12-02T14:26:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscontroversial-medicines-law-comes-into-force-in-el-salvador/ 2013-04-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-president-launches-100m-brain-research-project/ 2013-04-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscholesterol-drugs-could-treat-blinding-disease-say-us-scientists/ 2013-04-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-cancer-drug-patent-request-rejected-by-indian-court/ 2013-04-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrug-resistant-bug-can-spread-between-cystic-fibrosis-patients-study/ 2013-04-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremarch-stories-child-cured-hiv-astrazeneca-axes-jobs/ 2013-04-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/newsscientists-develop-method-for-entirely-synthetic-infectious-diseases-vaccine/ 2018-11-19T14:54:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbiogens-ms-drug-gets-fda-approval/ 2013-03-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizers-lung-cancer-drug-too-expensive-for-uk-health-watchdog/ 2013-03-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-recommends-two-treatments-for-cystic-fibrosis/ 2013-03-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureworld-pharmaceutical-frontiers-2012-mergers-deals/ 2013-03-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremexico-drugs-pharmaceutical-brazil-south-america/ 2022-11-30T04:33:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-wins-crestor-patent-case/ 2013-03-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbig-pharma-pay-for-delay-deal-with-generic-drug-company-considered-in-court/ 2013-03-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-teenage-cancer-deaths-down-but-more-access-to-clinical-trials-needed/ 2013-03-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsteva-blocks-propofol-use-in-lethal-injections/ 2013-03-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbio-modeling-systems-to-develop-technology-to-eliminate-allergy-testing-on-animals/ 2013-03-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-axes-2300-more-jobs-globally/ 2013-03-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsalmirall-gw-pharmaceuticals-may-pull-cannabis-drug-from-germany/ 2013-03-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspromising-new-antimalarial-to-enter-clinical-testing-phase/ 2013-03-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-to-create-new-rd-centre-in-cambridge-uk/ 2013-03-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsunder-skin-blood-testing-device-delivers-results-via-bluetooth/ 2013-03-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrug-resistant-swine-flu-could-spread-globally-say-australian-scientists/ 2013-03-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-grant-fast-track-status-to-new-alzheimers-treatment/ 2013-03-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newschina-to-assist-ghana-in-finding-origin-of-counterfeit-medicine-influx/ 2013-03-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-fast-tracks-novartis-rare-lung-cancer-treatment/ 2013-03-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-study-shows-hiv-can-be-functionally-cured-with-early-drug-treatment/ 2013-03-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newschina-pharma-posts-33-loss-owing-to-changes-in-healthcare-reform/ 2013-03-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-ema-approved-breast-cancer-drug-hailed-by-cancer-charities/ 2013-03-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-map-tapeworm-genetic-codes-to-find-new-treatments/ 2013-03-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsinterpol-teams-with-29-pharma-companies-to-crackdown-on-fake-drugs/ 2013-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsshire-acquires-infant-drug-to-treat-blinding-disease/ 2013-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureoutdoor-lab-growing-pharmaceuticals-plants-vaccines/ 2013-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-awards-rd-funding-to-valley-of-death-projects/ 2013-03-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaeterna-zentaris-cancels-phase-iii-trial-of-blood-cancer-drug-perifosine/ 2013-03-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseuropean-regulator-sued-by-abbvie-over-foi-request/ 2013-03-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsincentives-urgently-needed-to-develop-new-antibiotics-says-uk-health-chief/ 2013-03-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfewer-hiv-drugs-needed-for-treatment-experienced-patients-study/ 2013-03-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsminerva-biotechnologies-announces-major-breakthrough-in-human-stem-cell-research/ 2013-03-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-21/ 2023-04-12T06:35:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-men-missing-out-on-prostate-cancer-drugs/ 2013-03-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmercks-profits-more-than-double-as-rebif-demand-rises/ 2013-03-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-breath-test-can-diagnose-stomach-cancer/ 2013-03-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspneumococcal-disease-among-adults-causing-economic-burden-in-latin-america/ 2013-03-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsinflammation-causes-failure-in-drugs-to-halt-premature-labour/ 2022-09-19T11:18:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindia-rejects-bayers-appeal-to-revoke-generic-cancer-drug-license/ 2021-11-22T07:22:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-doctors-cure-child-of-hiv-with-standard-therapy/ 2013-03-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsoestrogen-patches-as-effective-as-injections-for-prostate-cancer/ 2013-03-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurefebruary-stories-takeda-anemia-drug-diane-35/ 2023-01-30T15:57:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgreece-frightened-as-multinational-drug-companies-halt-exports/ 2013-02-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsclinical-trials-of-a-placental-malaria-vaccine-to-be-funded-by-eu/ 2013-02-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-warns-that-at-least-fifty-drugs-react-negatively-with-grapefruit/ 2013-02-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-supreme-court-backs-amgen-shareholders-to-sue-company-as-a-group/ 2013-02-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaction-plan-launched-to-combat-untreatable-gonorrhoea-in-uk/ 2013-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindia-proposes-patented-drugs-be-priced-in-line-with-countrys-per-capita-income/ 2013-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-create-effective-passport-for-therapeutic-devices-entering-the-body/ 2013-02-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-cancer-drug-stivarga-for-advanced-gastrointestinal-stromal-tumors/ 2013-02-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbrain-cells-ability-to-survive-stroke-explained-by-uk-scientists/ 2013-02-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstakeda-pulls-anemia-drug-omontys-after-fatal-hypersensitivity-reactions/ 2013-02-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-develop-promising-new-flu-drug/ 2013-02-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-announce-top-line-results-for-phase-iii-epilepsy-drug-trial/ 2013-02-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureunravelling-eu-parallel-drug-trade-dilemma/ 2013-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-drug-discovery-not-falling-say-experts/ 2013-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnanologix-petri-plate-technology-breaks-storage-records/ 2013-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-drug-research-falling-into-valley-of-death-says-professor/ 2013-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-european-patent-court-to-be-built-in-london/ 2013-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-to-scrap-controversial-payout-to-chairman-daniel-vasella/ 2013-02-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaustralian-government-to-provide-220m-subsidy-for-important-medicines/ 2013-02-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgilead-sciences-recalls-batch-of-vistide-drug-for-aids-patients/ 2013-02-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdiamond-sheds-light-on-dangerous-viruses/ 2013-02-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-court-support-validity-of-astrazenecas-seroquel-xr/ 2013-02-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-will-explore-arctic-seabed-to-research-new-antibiotics/ 2013-02-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsesteemed-psychiatrist-defends-off-label-drug-prescription/ 2013-02-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsphrma-attacks-obamas-proposals-to-cut-medicare-payments/ 2013-02-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuniversity-of-dundee-launches-discovery-centre-for-infectious-diseases/ 2018-11-19T14:55:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovozymes-epivax-to-develop-combination-therapy-for-autoimmune-diseases/ 2013-02-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssmc-approve-stroke-prevention-drug-eliquis-for-use-within-nhs-scotland/ 2013-02-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssun-pharma-taro-terminate-merger-deal/ 2021-11-22T08:01:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-launch-review-of-acne-drug-diane-35/ 2013-02-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscrisis-in-syria-hits-pharma-industry-and-drug-supplies/ 2013-02-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-regulator-concerned-over-increase-of-illegal-eastern-european-drugs/ 2013-02-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharma-company-found-responsible-for-213-deaths-in-pakistan/ 2013-02-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newselan-restructures-tysabri-collaboration-with-biogen-in-325bn-deal/ 2013-02-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-196m-european-drug-discovery-platform-launched/ 2013-02-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-announces-plans-to-publish-detailed-drug-data-old-and-new/ 2013-02-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrug-testing-to-speed-up-with-worlds-first-3d-stem-cell-printer/ 2013-02-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgenetic-patch-potential-prevention-of-hereditary-deafness/ 2013-02-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstb-vaccine-fails-to-protect-infants-in-south-africa/ 2013-02-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-blocks-astrazeneca-bms-drug/ 2013-02-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-law-ensures-adequate-compensation-for-drug-trial-victims-india/ 2013-02-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejanuary-stories-gsk-court-diabetes-drug-fda-approval-high/ 2013-01-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsinvisibility-cloak-helps-nanoparticles-target-tumours/ 2013-01-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroches-phase-iii-leukemia-drug-yields-positive-results/ 2013-01-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmorning-after-pill-conscience-clause-should-be-banned-say-pharmacists/ 2013-01-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfrance-suspends-bayers-diane-35-sales-after-deaths/ 2013-01-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-boosted-by-cancer-drug-sales/ 2013-01-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-set-for-compensation-battle-in-uk-over-avandia-diabetes-drug/ 2013-01-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsconsultation-into-public-disclosure-of-payments-to-healthcare-workers-launched-inuk/ 2013-01-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-forms-jv-with-biological-e-to-develop-six-in-one-paediatric-vaccine/ 2013-01-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-takeda-diabetes-drug-after-long-wait/ 2013-01-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearch-using-stem-cells-shows-promise-for-stroke-patients/ 2013-01-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-hospital-trials-painbuster-in-mastectomy-patients/ 2013-01-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssystem-used-to-choose-drugs-on-nhs-criticised-in-new-report/ 2013-01-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretrialing-first-ever-hiv-vaccine-human-clinical/ 2013-01-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfirst-drug-combination-for-pancreatic-cancer-increases-survival-rates/ 2013-01-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscontroversial-research-into-the-spreading-of-bird-flu-will-continue/ 2013-01-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-anti-stroke-drug-apixaban-now-available-on-uk-nhs/ 2013-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovo-nordisk-gets-eu-approval-for-tresiba-and-ryzodeg/ 2013-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-gets-european-approval-for-first-meningitis-b-vaccine/ 2013-01-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssynthon-biopharmaceuticals-reports-positive-results-from-pre-clinical-cancer-antibody-drug-study/ 2013-01-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsquadruple-dna-discovery-could-lead-to-novel-cancer-treatment/ 2013-01-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-device-tests-multiple-cancer-drugs-on-living-tumours/ 2013-01-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstransplant-rejection-drug-could-be-used-to-treat-malaria/ 2013-01-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsrise-in-industry-settlements-that-delay-generic-drugs-to-market/ 2013-01-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-discover-potential-new-treatment-for-certain-digestive-cancers/ 2013-01-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-first-flu-vaccine-made-using-insect-virus/ 2013-01-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsclinicians-left-in-dark-over-new-drug-pricing-system-uk-health-report/ 2013-01-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfirst-once-daily-liquid-adhd-drug-becomes-available-in-us/ 2013-01-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgeneric-hiv-drugs-cost-efficient-but-less-effective/ 2013-01-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-recommends-drugs-to-prevent-breast-cancer-in-high-risk-groups/ 2013-01-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-files-type-2-diabetes-drug-for-fda-approval/ 2013-01-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjohnson-johnson-go-to-court-over-vaginal-mesh-gynecare-prolift/ 2013-01-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsteva-pleas-with-fda-to-evaluate-safety-of-biogens-ms-pill/ 2013-01-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstext-message-system-helps-consumers-fight-against-counterfeit-drugs/ 2013-01-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmedical-breaks-from-roches-zelboraf-cause-melanoma-tumours-to-shrink-study/ 2013-01-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresearchers-accused-of-mis-reporting-breast-cancer-clinical-trial-results/ 2023-01-24T16:05:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-biobank-stem-cell-partnership-hopes-to-speed-up-drug-delivery/ 2013-01-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaustralias-clinical-network-service-acquires-beltas-business-assets/ 2013-01-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-msd-accused-of-conducting-illegal-vaccine-trials-on-indian-girls/ 2013-01-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-research-suggests-beta-blockers-may-lower-dementia-risk/ 2013-01-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-makes-u-turn-decision-on-lucentis/ 2013-01-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnhs-accused-of-hampering-drug-trials-due-to-lack-of-information/ 2013-01-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssisters-sue-drug-eli-lilly-over-des-drug-breast-cancer-link/ 2013-01-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbiogen-idec-empower-phase-iii-als-drug-trial-fails/ 2013-01-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretesting-painful-stimuli-painkillers-human-volunteers/ 2013-01-03T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvictory-pharma-settles-civil-lawsuit-with-114m-fine/ 2013-01-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsradius-and-3m-drug-delivery-systems-form-partnership/ 2013-01-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-hits-drug-approval-15-year-high/ 2013-01-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approve-first-drug-resistant-tb-treatment-in-40-years/ 2013-01-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsradius-and-3m-drug-delivery-systems-join-in-exclusive-partnership/ 2012-12-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamericans-split-in-opinion-about-medicare-reform/ 2012-12-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureyear-in-review-2012-top-pharmaceutical-stories/ 2012-12-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvismodegib-team-wins-drug-discovery-of-the-year-award/ 2012-12-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharma-companies-forced-to-declare-individual-payments-to-australian-doctors/ 2012-12-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-20/ 2023-04-12T06:38:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbig-pharma-pushing-unproven-drugs-in-poland-study/ 2012-12-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-serono-lung-cancer-drug-fails-to-meet-its-primary-endpoint-in-phase-iii-trials/ 2023-01-24T16:04:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-first-quad-vaccine-to-cover-four-flu-strains/ 2012-12-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsrise-in-consumers-buying-prescription-meds-online/ 2012-12-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-scientists-demonstrate-speedier-tb-diagnostic-technology/ 2012-12-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approve-raxibacumab-for-inhalational-anthrax-under-its-animal-efficacy-rule/ 2023-04-04T08:02:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdiabetes-drug-may-hold-key-to-alzheimers-cure/ 2012-12-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseli-lilly-ends-rheumatoid-arthritis-trial-due-to-lack-of-efficacy/ 2012-12-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsautomated-design-system-could-speed-up-drug-development-says-university/ 2012-12-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-seeks-to-prevent-indias-cipla-from-selling-cancer-drug/ 2012-12-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuresyria-war-drug-medicine-supply-medicins-sans-frontieres/ 2012-12-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamgen-acquires-genetics-firm-decode/ 2012-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfairer-pricing-for-hiv-drugs-needed-says-us-frontline-care-providers/ 2012-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspositive-results-ferumoxytol-phase-iii-trial/ 2023-04-05T10:15:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroches-perjeta-reduces-breast-cancer-deaths/ 2012-12-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-to-launch-national-dna-database-for-cancer-patients/ 2012-12-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbicycle-therapeutics-lands-37m-drug-discovery-fund/ 2012-12-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-drug-discovery-potential-after-pathway-to-depression-discovered/ 2012-12-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovavax-reports-positive-results-from-rsv-vaccine-study/ 2012-12-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurenovember-illegal-drug-testing-india-us-iran-pharma/ 2012-12-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseus-innovative-medicines-initiative-launches-seven-new-drug-discovery-programmes/ 2012-12-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuniversity-of-florida-launches-hearing-drug-trial-using-ipods/ 2012-12-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-court-reverses-off-label-drug-promotion-conviction-of-sale-rep/ 2012-12-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsoxford-vacmedix-to-introduce-cost-effective-technology-for-vaccine-development/ 2012-12-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsalimera-considers-iluvien-price-cut-after-nice-rejection/ 2012-12-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaltravax-receives-nih-grants-for-hiv-vaccine-development/ 2012-12-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsproduct-hopping-pharma-firms-should-be-taken-to-court-says-us-commission/ 2012-12-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-serono-partners-with-neopharma-for-middle-east-production/ 2012-12-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssouth-africa-awards-major-hiv-drug-supply-contract/ 2012-11-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-cometriq-for-metastatic-mtc/ 2012-11-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsariad-announces-results-of-phase-i-ponatinib-study/ 2012-11-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbig-pharma-increasing-access-to-drugs-in-poor-countries-index/ 2012-11-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsselecta-partners-with-sanofi-to-develop-anti-allergy-immunotherapies/ 2012-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbracco-voluntarily-recalls-isovue-pre-filled-syringes/ 2012-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepeople-power-crowdfunding-clinical-research-funding/ 2012-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-pfizer-to-develop-research-centre-in-qubec/ 2012-11-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsquintiles-partners-with-cra-to-improve-clinical-trial-participation/ 2012-11-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharmaceutical-supply-chain-cloud-infrastructure-clinical-trials/ 2022-07-11T08:58:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsapitope-completes-recruitment-for-multiple-sclerosis-trial/ 2012-11-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-recommends-orphan-product-status-for-aspireos-somatoprim/ 2012-11-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-lowers-price-of-viagra-in-canada/ 2012-11-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-government-considering-investigation-into-unpublished-trial-data/ 2012-11-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-bristol-gain-approval-for-blood-thinner-eliquis/ 2012-11-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscash-boost-allows-valirx-to-start-clinical-trial-for-anti-cancer-drug/ 2012-11-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-19/ 2023-04-12T06:30:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsacura-announces-results-of-safety-enhanced-nexafed-study/ 2012-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscottish-mp-to-face-scrutiny-over-branding-pharmacists-as-methadone-millionaires/ 2012-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgenting-invests-1118m-in-taurx-pharmaceuticals/ 2012-11-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-recommends-sanofis-diabetes-and-colon-cancer-drugs/ 2012-11-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsxenetic-ms-vaccine/ 2012-11-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-novartis-meningitis-b-vaccine/ 2023-06-30T06:01:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsthere-major-drug-companies-clinical-trial-database/ 2012-11-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstranzyme-stomach-paralysis-drug-fails-study/ 2012-11-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharmaceutical-drug-black-market-cargo-theft/ 2012-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-committee-recommends-approval-of-gsks-bird-flu-vaccine/ 2012-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsconcerns-from-clinician-sparks-scottish-nhs-drug-access-review/ 2012-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgermany-finds-seroquel-xr-patent-invalid/ 2012-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsinternational-treaty-to-protect-public-from-fake-drugs-needed-say-experts/ 2012-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsleading-journal-condemns-roche-for-failing-to-disclose-full-tamiflu-data/ 2012-11-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfirm-blamed-for-meningitis-outbreak-was-not-fit-to-manufacturer-drugs-in-2003-report/ 2023-06-30T06:04:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscelgenes-abraxane-improves-pancreatic-cancer-survival-rates/ 2012-11-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-breached-abpi-codes-when-promoting-drug-revolade/ 2012-11-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureobama-live-up-to-his-promises-aids/ 2012-11-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstesting-pain-killers-on-humans-could-increase-efficiency-and-save-time-and-money/ 2012-11-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharmaceutical-plant-explosion-in-canada-kills-two/ 2012-11-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-mimic-lung-disease-on-a-microchip/ 2012-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-analysis-of-pradaxa-may-be-flawed-report/ 2012-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshiv-preventative-vaccine-shows-no-adverse-effects-in-human-trial/ 2012-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsanxiety-and-allergy-medication-could-harm-memory-in-elderly/ 2012-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-to-present-preliminary-results-of-first-ever-human-trial-on-hiv-vaccine/ 2012-11-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscambridge-company-to-supply-stem-cells-for-drug-discovery/ 2012-11-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharmaceutical-companies-offer-to-cap-greeces-drug-bill/ 2012-11-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-approves-janssen-and-bayers-xarelto-for-blood-clots/ 2012-11-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-gsk-drugs-shrink-brain-tumours-in-patients-with-advanced-breast-cancer/ 2022-07-11T08:58:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-eases-sanctions-on-selling-meds-to-iran/ 2012-11-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscancer-drug-has-superior-effects-over-first-line-ms-treatments/ 2012-10-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindias-poor-possibly-used-in-illegal-drug-trials-without-their-consent/ 2022-07-11T08:58:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-october-stories-cardiologists-noble-prize-meningitis-outbreak/ 2023-03-31T10:42:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-scientists-bag-funding-to-investigate-on-hold-astrazeneca-drugs/ 2012-10-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstaurx-therapeutics-alzheimers-drug-enters-a-two-phase-third-trial/ 2022-07-11T08:58:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmenarini-group-and-oxford-biotherapeutics-collaborate-to-create-antibody-drugs/ 2012-10-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshurricane-sandy-delays-healthcare-earnings-reports/ 2012-10-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuse-of-novartiss-anti-influenza-vaccine-halted-by-eu-member-states/ 2012-10-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmassachusetts-shuts-down-second-compounding-pharmacy/ 2012-10-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureshort-supply-tackling-drug-shortage-crisis/ 2012-10-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-ingelheim-settles-false-claims-lawsuit-with-95m-payout/ 2012-10-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfaecal-transplants-eradicate-c-difficile-in-mice/ 2012-10-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/feature-pursuing-alzheimers-disease-breakthrough/ 2012-10-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsoxfam-slams-dangerous-malaria-drugs-financing-scheme/ 2012-10-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-wants-to-attract-new-drug-developments-by-cutting-patent-risk-factor/ 2012-10-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssterility-failures-found-at-drug-compounder-blamed-for-us-meningitis-outbreak/ 2012-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseu-parliament-approves-eu-israel-medicines-trade-pact/ 2012-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-mp-calls-for-full-drug-trial-report-disclosure/ 2012-10-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-enters-deal-to-acquire-nextwave-pharmaceuticals/ 2012-10-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseuropean-health-agency-recommends-novo-nordisks-high-dose-insulin-treatment/ 2023-01-05T06:18:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseu-parliament-to-vote-on-removal-of-pharmaceutical-trade-barriers-between-eu-and-israel/ 2012-10-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglobal-health-foundations-to-collaborate-on-tb-drug-development/ 2012-10-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-meningitis-update-four-more-dead-and-necc-lab-raided/ 2012-10-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbird-flu-vaccine-achieves-primary-objective-in-phase-i-clinical-trials/ 2012-10-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-18/ 2023-04-12T06:38:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharmaceutical-science-lance-armstrong-doping-peloton/ 2021-10-22T08:06:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsabbott-hepatitis-c-treatment-suppresses-virus/ 2012-10-17T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsirish-pharma-strikes-supply-deal-to-reduce-medicine-costs/ 2012-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscancer-drug-sales-drive-growth-for-roche/ 2012-10-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstwo-more-drugs-believed-to-be-contaminated-in-the-us-meningitis-outbreak/ 2012-10-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-to-acquire-hcmv-drug-portfolio/ 2012-10-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmental-health-drug-development-has-come-to-a-stand-still-say-experts/ 2012-10-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsoxford-biomedica-closes-prostate-cancer-trial/ 2012-10-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsthree-drugs-chosen-worldwide-alzheimers-clinical-study/ 2012-10-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-to-share-detailed-drug-data/ 2012-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnobel-prize-awarded-to-two-cardiologists-who-paved-the-way-for-thousands-of-drugs/ 2012-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureus-elections-2012-stem-cell-research/ 2012-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-dementia-summit-tackle-drug-development-challenges/ 2012-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-pharmaceutical-research-centre-set-for-birmingham-uk/ 2012-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsadvinus-takeda-pharmaceutical-forces-develop-therapeutic-drugs/ 2012-10-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuniversity-texas-lab-speed-up-pre-human-clinical-trials/ 2022-07-11T08:58:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-drug-could-reduce-brain-damage-caused-by-strokes-study/ 2012-10-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-jointly-awarded-nobel-prize-for-their-revolutionary-stem-cell-research/ 2012-10-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmillions-of-counterfeit-and-unlicensed-drugs-seized-during-worldwide-crackdown/ 2012-10-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsblack-mamba-snake-venom-as-powerful-as-morphine/ 2012-10-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsresponsible-drug-use-could-save-500bn-per-year-report/ 2012-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-stops-production-of-generic-anti-depressant-budeprion-xl-300/ 2012-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-drops-legal-case-against-nhs-cluster/ 2012-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approve-first-liquid-drug-for-adhd-quillivant-xr/ 2012-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurealzheimers-study-snake-venom-cancer-cure-enquiry/ 2012-10-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-announces-endpoint-results-of-phase-iii-renal-cell-carcinoma-comparz-trial/ 2022-09-09T11:46:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-drug-shows-promise-against-aggressive-breast-cancer/ 2012-10-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfrench-drug-giant-servier-enter-into-agreement-to-aid-development-of-alzheimers-drug/ 2012-09-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrug-resistant-salmonella-made-stronger-by-hiv-study/ 2022-07-29T11:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretackling-pharmaceutical-counterfeits-beyond-packaging/ 2012-09-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshpa-advise-pregnant-women-to-get-vaccinated-after-significant-rise-in-whooping-cough/ 2012-09-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsanxiety-drug-benzodiazepine-could-increase-dementia-risk-study/ 2012-09-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofi-to-cut-fewer-jobs-than-expected/ 2012-09-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstype-2-diabetes-drug-breakthrough-could-prevent-onset-and-progression/ 2023-01-05T06:18:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsreckitt-benckiser-discontinues-sale-of-suboxone-heroin-tablets-in-the-us/ 2012-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdown-syndrome-pilot-study-commissioned-by-j-j-to-develop-possible-alzheimers-drug/ 2012-09-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-hospitals-warned-over-medicare-fraud/ 2012-09-25T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/news1m-eurostars-grant-awarded-for-the-development-of-a-placental-malaria-vaccine/ 2012-09-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbristol-myers-squibb-vanderbilt-university-collaborate-for-parkinsons-research/ 2012-09-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharmaceutical-sector-outlook-raised-from-negative-to-stable-by-moodys/ 2012-09-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssuccessful-trial-of-new-ms-drug-shows-reduction-in-relapses/ 2012-09-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsworld-alzheimers-day-uk-charity-pledges-funding-as-drug-companies-retreat-from-dementia-studies/ 2012-09-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsthousands-of-uk-citizens-miss-out-on-diabetes-treatment/ 2012-09-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmajor-drug-companies-form-non-profit-to-improve-drug-development-processes/ 2012-09-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-17/ 2023-04-12T06:39:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-warns-of-laboratorios-lopez-drug-danger/ 2012-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-understanding-of-snake-venom-could-identify-new-cancer-drugs/ 2012-09-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfurther-development-of-targacept-adhd-drug-scrapped-after-failed-study/ 2012-09-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-suffers-second-setback-for-erbitux-cancer-drug/ 2012-09-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuredeadly-infection-anthrax-outbreak-health-agency/ 2023-04-04T08:02:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstwo-professors-label-half-of-prescribed-drugs-in-france-either-useless-or-dangerous/ 2012-09-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-launches-generics-jv-in-china/ 2021-12-02T06:29:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsadvanced-phytoestrogen-study-could-lead-to-tailor-made-health-products/ 2012-09-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-mps-plan-inquiry-into-nice/ 2012-09-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofi-multiple-sclerosis-treatment-wins-us-approval/ 2012-09-13T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsloreal-warned-for-mislabeling-cosmetics-as-pharmaceutical-products/ 2012-09-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofi-dengue-fever-vaccine-shows-potential/ 2012-09-12T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstakeda-completes-pharma-manufacturing-plant-in-russia/ 2012-09-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindian-supreme-court-begins-final-hearing-on-glivec-patent-case/ 2012-09-11T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspro-bono-bio-obtains-licence-for-polytherics-therapeg-technology/ 2012-09-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-health-bodies-alerted-after-latest-anthrax-death/ 2012-09-10T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-pulls-obesity-drug-after-allergic-reaction/ 2012-09-10T02:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjazz-pharma-spins-off-womens-health-business-for-95m/ 2012-09-07T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsa-new-setback-for-eli-lilly-as-lung-cancer-drug-trial-fails/ 2012-09-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrug-advisory-panel-backs-novartis-cystic-fibrosis-drug/ 2012-09-06T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshuman-genome-contains-vital-gene-control-panel-study/ 2012-09-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-leukaemia-drug-receives-us-approval/ 2012-09-05T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsunipolar-depression-market-presents-major-opportunities-report/ 2012-09-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-to-cut-1100-jobs-in-germany/ 2012-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvaleant-to-acquire-medicis-for-26-billion/ 2012-09-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-questions-efficacy-of-novartis-cystic-fibrosis-drug-tobramycin/ 2012-09-03T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-boehringer-drug-delays-asthma-attacks/ 2012-09-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslilly-pulls-schizophrenia-treatment-after-phase-iii-failure/ 2022-12-29T06:55:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-drug-offers-hope-to-tamoxifen-resistant-breast-cancer-patients/ 2022-07-11T08:58:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgenmab-and-jj-ink-11bn-cancer-agreement/ 2012-08-30T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newswest-nile-virus-death-toll-rises-in-the-us/ 2022-08-11T12:57:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssun-pharma-unit-caraco-can-resume-drug-production/ 2012-08-28T22:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-compound-offers-hope-for-malaria-cure/ 2012-08-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-green-lights-gileads-new-hiv-combination-treatment/ 2012-08-28T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshealth-canada-approves-lundbecks-treanda/ 2023-01-17T10:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbristol-myers-squibb-forced-to-drop-hepatitis-c-drug-following-patient-death/ 2022-07-11T08:58:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstimely-use-of-prophylaxis-recommended-to-save-sick-babies/ 2012-08-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsallergan-and-molecular-ink-new-deals-totalling-15bn-extending-alliance/ 2012-08-23T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurebio-defence-threat-gsk-novartis-emergent-biosolutions/ 2012-08-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsorphan-drugs-are-economically-viable-studies-show/ 2012-08-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-extends-review-of-pfizers-tofacitinib/ 2012-08-22T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newswockhardt-to-sell-generic-copy-of-pfizers-geodon-in-india/ 2012-08-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofi-pulls-leukaemia-drug-campath-prior-to-its-relaunch-as-lemtrada/ 2012-08-21T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurefda-response-drug-shortages-medication/ 2012-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsunited-drug-to-acquire-bilcare-global-clinical-supplies/ 2012-08-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbig-pharma-awaits-indian-patent-ruling/ 2012-08-20T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstrio-launch-actos-generics/ 2012-08-20T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsexperimental-asthma-drug-halves-attacks-in-hard-to-treat-form-of-disease/ 2012-08-17T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssmall-molecule-provides-first-step-for-male-contraceptive-development/ 2012-08-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssantarus-files-patent-infringement-lawsuit-against-dr-reddys/ 2012-08-16T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurefda-drug-development-patient-health/ 2022-07-11T08:58:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-diabetes-prescriptions-top-40-million/ 2012-08-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-16/ 2023-04-12T06:30:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssun-pharmaceuticals-to-acquire-remaining-taro-shares/ 2012-08-15T02:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsaspen-acquires-gsk-product-portfolio/ 2012-08-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-to-acquire-over-the-counter-nexium-marketing-rights-from-astrazeneca/ 2012-08-14T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newselan-spins-off-research-arm/ 2012-08-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgenentech-lucentis-receives-fda-approval/ 2023-01-23T12:53:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureeu-api-regulation-imported-pharmaceutical-july-2013/ 2012-08-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdutch-regulatory-agency-rejects-cosmo-drug/ 2012-08-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamgen-forced-to-halt-ganitumab-study/ 2012-08-10T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-talons-rare-leukaemia-drug/ 2012-08-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvaccine-advice-website-warned-over-mmr-autism-claims/ 2012-08-09T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvotrient-approval-provides-first-oral-therapy-for-rare-cancer-patients-in-the-uk/ 2012-08-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-fined-and-teva-investigated-as-part-of-major-bribery-crackdown/ 2012-08-08T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbristol-myers-squibb-executive-charged-with-insider-trading/ 2012-08-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepatent-cliff-plummeting-blockbuster-drug-sales-2011-2012/ 2012-08-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-jj-alzheimers-drug-scrapped-after-failure-in-second-study/ 2012-08-07T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofis-colon-cancer-drug-gets-us-approval/ 2012-08-07T00:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscephalon-products-provide-sales-boost-teva/ 2012-08-06T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuganda-battles-to-control-ebola-outbreak/ 2012-08-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglaxosmithkline-completes-hgs-acquisition/ 2012-08-03T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbristol-myers-squibb-halts-hepatitis-c-drug-trial/ 2012-08-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-solid-despite-lipitor-sales-slump/ 2012-08-02T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsanti-doping-centre-provide-phenome-research-post-london-games/ 2012-08-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsalzheimers-drug-shows-new-potential/ 2012-08-01T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurejulys-top-stories-trials-lawsuits-drug-discoveries/ 2012-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-launches-parkinsons-spin-off-company/ 2012-07-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsariad-seeks-accelerated-approval-leukaemia-drug/ 2012-07-31T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsexelixis-priority-review-thyroid-cancer-drug/ 2012-07-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbreast-cancer-drug-afinitor-gets-european-nod/ 2012-07-30T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-returns-rights-to-acura-products/ 2012-07-30T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindia-to-consider-patented-drug-price-controls/ 2012-07-27T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-study-shows-potential-for-eradicating-hidden-hiv-pools/ 2012-07-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslundbeck-eu-antitrust-complaint/ 2012-07-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsworld-vaccine-market-338bn-in-2012/ 2012-07-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdengue-fever-vaccine-protects-against-3-strains/ 2012-07-25T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovavax-vaccine-meets-primary-endpoints/ 2012-07-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-jj-alzheimers-drug-fails-late-stage-trial/ 2012-07-24T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsover-150-aids-drugs-available-worldwide/ 2012-07-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-successful-lyrica-patent-lawsuit/ 2012-07-23T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureeuropean-clinical-trials-directive-2012/ 2012-07-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglybera-eus-1st-recommended-gene-therapy/ 2023-01-04T11:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofi-pencils-cholesterol-drug-launch-for-2015/ 2012-07-20T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-flaunts-delayed-aids-drug-funds-says-charity/ 2012-07-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindian-pharmaceutical-industry-agrees-to-enforced-marketing-code/ 2012-07-19T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsall-in-one-polypill-to-save-thousands-of-lives/ 2012-07-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-focus-technology-issue-15/ 2012-07-18T05:21:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-busts-108m-drug-black-market/ 2012-07-18T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureuk-biobank-patient-data/ 2012-07-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-vivus-obesity-drug/ 2012-07-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshiv-prevention-drug-truvada-receives-us-approval/ 2012-07-17T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-malaria-vaccine-to-be-developed-in-india/ 2012-07-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglaxosmithkline-expected-to-wrap-up-human-genome-sciences-acquisition/ 2012-07-16T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-opens-anti-doping-lab-london-2012-olympic-games/ 2012-07-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharmaceutical-spend-in-emerging-markets-to-double-by-2016/ 2012-07-13T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-to-file-global-approval-of-diabetes-drug/ 2012-07-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjanssen-pharmaceuticals-licenses-potential-diabetes-treatments-from-evotec/ 2012-07-12T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsalzheimers-predicted-25-years-before-memory-loss-study/ 2012-07-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgates-foundation-unveils-contraception-funding/ 2012-07-11T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbristol-myers-squibb-launches-tender-offer-for-amylin-shares/ 2012-07-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecybercrime-pharmaceutical-industry-biotech/ 2012-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharma-industry-training-opioid-prescriptions/ 2012-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharmaceutical-firms-gates-foundation-tb-drugs/ 2012-07-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-defends-itself-against-lipitor-lawsuit/ 2012-07-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsstudy-ms-patients-certain-class-drugs/ 2012-07-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamgen-closes-kai-pharmaceuticals-deal/ 2012-07-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofi-may-cut-up-to-2000-jobs-in-france/ 2012-07-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-indian-policy-to-provide-free-generic-drugs/ 2012-07-05T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuresuperhydrophobic-drug-cancer-surgical-oncologist/ 2012-07-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsstudy-reveals-growing-number-of-drug-resistant-tb-cases/ 2012-07-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslink-found-diabetes-pregnancy-antipsychotic-drugs/ 2012-07-04T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsweakening-malaria-drug-still-effective-in-mali-study/ 2012-07-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglaxosmithkline-settles-record-healthcare-fraud-case/ 2012-07-03T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjohnson-johnson-approval-new-tb-medicine/ 2012-07-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindian-drug-marketing-code-mandatory/ 2012-07-02T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbristol-myers-squibb-astrazeneca-7bn-diabetes-partnership/ 2012-07-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-supreme-court-upholds-overhaul-of-us-healthcare-system/ 2012-06-29T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshiv-quad-pill-is-safe-and-effective-study/ 2012-06-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-belviq-but-issues-patient-warning/ 2022-07-11T08:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnicotine-vaccine-to-help-smokers-quit/ 2012-06-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-urged-to-reject-lorcaserin-by-consumer-group/ 2012-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbristol-myers-squibb-to-double-original-share-buyback/ 2012-06-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrug-industry-higher-clinical-development-success-rates/ 2012-06-26T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureskin-redefining-drug-delivery-implantable-microchips/ 2012-06-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-recalls-mmr-vaccines-from-the-us/ 2012-06-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseuropean-drug-concessions-secure-medicine-supplies/ 2012-06-25T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdeadly-bird-flu-pandemic-possible-study/ 2012-06-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsema-to-investigate-roche-over-drug-safety-reporting-failures/ 2012-06-22T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofi-harvard-to-develop-diabetes-drugs/ 2012-06-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureblood-drive-medical-devices-pilot-bloodstream/ 2012-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-halts-obesity-trial-after-patient-suffers-allergic-reaction/ 2012-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsepigenetic-drug-discovery/ 2012-06-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-focus-technology-issue-14/ 2012-06-20T04:33:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-snares-access-to-ac-immune-alzheimers-drug/ 2012-06-20T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsabbott-positive-results-parkinsons-intestinal-gel-trial/ 2012-06-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshuman-genome-sciences-sets-acquisition-deadline/ 2012-06-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuniversity-of-oxford-population-genetics-diabetes-heart-attack-studies/ 2012-06-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslundbeck-slash-european-sales-force-restructure/ 2012-06-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvaleant-acquistion-purchase-orapharma/ 2012-06-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroches-avastin-shrinks-tumours-study/ 2012-06-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-rejects-melanoma-drug/ 2012-06-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurenanotechnology-cancer-cure-drug/ 2012-06-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsreal-time-genome-sequencing-reduce-healthcare-costs/ 2012-06-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscancer-killing-virus-hitchhike-blood-cells/ 2012-06-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjazz-pharmaceuticals-eusa-pharma-acquisition/ 2012-06-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-unit-exclusive-rights-basilea-eczema-drug/ 2012-06-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglaxosmithkline-extends-share-offer-human-genome-sciences/ 2012-06-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newssanofi-approval-europe-us-agencies-ms-drug/ 2012-06-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjohnson-johnson-charges-risperdal-marketing/ 2012-06-11T04:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroches-late-stage-breast-cancer-drug-approved-fda/ 2012-06-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-restructure-spin-off-animal-health-business/ 2012-06-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsunicef-pneumonia-diarrhoea-prevention-children/ 2012-06-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsunregulated-antibiotics-untreatable-gonorrhoea/ 2012-06-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-cuts-jobs-lipitor-production/ 2012-06-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-kgaa-dr-reddys-biosimilar-pact/ 2012-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstakeda-800m-purchase-url-pharma/ 2012-06-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-ingelheim-european-pilot-plant/ 2012-05-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-to-lift-ban-lethal-injections/ 2012-05-31T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-funding-bill-approved/ 2012-05-31T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscientists-catalogue-childhood-cancer-dna/ 2012-05-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremobile-revolution-drug-developers-smart-device-technology/ 2021-12-07T08:15:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshuman-genome-sciences-sued-poison-pill/ 2012-05-30T02:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnurofen-tamperer-prison-sentence/ 2012-05-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseu-fund-global-leukaemia-study/ 2012-05-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslundbeck-alzheimers-drug-positive-results/ 2012-05-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstakeda-multilab-acquisition/ 2012-05-28T02:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscity-of-hope-t-cell-treatment-brain-tumours/ 2012-05-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-requests-hgs-to-invalidate-poison-pill/ 2012-05-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspharma-companies-drug-resistant-bacteria/ 2012-05-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgreece-hit-with-essential-medicine-shortage-caused-by-mounting-drug-debt/ 2012-05-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslong-lasting-birth-control-better-than-pill-study/ 2012-05-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-drug-tafamidis-approval-setback/ 2012-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-identifies-autoimmune-reactions/ 2012-05-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfake-anti-malarial-drugs-resistance/ 2012-05-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovavax-sells-10-million-shares-to-ra-capital-healthcare-fund/ 2012-05-21T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-bloodthinner-plavix-patent-expiry/ 2012-05-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdr-reddys-launches-lansoprazole/ 2012-05-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsworlds-first-approved-stem-cell-drug-marketing-clearance/ 2012-05-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshgs-poison-pill-protect-against-gsk-takeover/ 2012-05-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsreneurons-stroke-therapy-phase-2/ 2012-05-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-raises-stake-in-theravance/ 2021-11-25T10:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-13/ 2023-04-12T06:34:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-rejects-sanofi-appeal-over-cancer-drug-jevtana/ 2012-05-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-prostate-cancer-drug-decision/ 2012-05-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newscannabis-ease-pain-ms-sufferers/ 2023-03-15T08:48:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuredangers-unreported-clinical-trial-data-medicine/ 2022-07-11T08:58:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-acquire-shares-in-cellzome/ 2012-05-14T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-warning-ms-treatment/ 2012-05-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-panel-backs-obesity-drug-lorcaserin-for-approval/ 2012-05-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslipitor-generics-save-nhs-350m-year/ 2012-05-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgilead-sciences-truvada-gets-fda-nod-for-hiv-prevention/ 2012-05-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureclinical-data-management-strategy/ 2012-05-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglaxosmithkline-intensifies-hostile-bid-for-human-genome-sciences/ 2012-05-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovavax-trial-bird-flu-vaccine/ 2012-05-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsabbott-settles-depakote-investigation-with-16bn-bill/ 2012-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsone-in-six-cancers-caused-by-preventable-infections-study/ 2012-05-08T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsabbott-laboratories-acquires-new-kidney-drug/ 2012-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspositive-results-for-lundbecks-schizophrenia-drug-trial/ 2012-05-07T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-purchase-of-fougera/ 2012-05-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfailed-drugs-to-be-tested-against-new-illnesses/ 2012-05-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdengue-fever-more-costly-than-malaria/ 2012-05-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-yale-university-fight-disease-causing-proteins/ 2012-05-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsteva-settles-litigation-with-mylan-over-nuvigil/ 2012-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsone-in-20-prescriptions-occur-in-error-uk-study/ 2012-05-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindian-pharmaceutical-plant-fire-kills-four/ 2012-04-30T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureplasma-based-virus-treatment-adenovirus-hiv/ 2012-04-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsvivus-viagra-rival-stendra-receives-fda-approval/ 2012-04-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrugs-could-mend-faulty-gene-in-aggressive-pancreatic-cancer/ 2012-04-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newswatson-to-become-third-largest-generics-firm-with-actavis-acquisition/ 2012-04-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjazz-pharmaceuticals-to-acquire-eusa/ 2012-04-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurerobotic-research-pharmaceutical-robot-eve/ 2022-02-03T02:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-ceo-quits-as-profits-tumble/ 2012-04-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamgen-acquires-majority-stake-in-turkeys-mustafa-nevzat-pharmaceuticals/ 2012-04-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-to-slash-swiss-jobs-in-restructure/ 2012-04-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshpa-reports-22-increase-in-uk-malaria-infections-acquired-in-indian-subcontinent/ 2012-04-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuredrug-addiction-medication-vaccine-drug-abuse/ 2022-09-27T10:22:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovo-nordisk-oxford-university-partner-to-find-new-inflammatory-disease-treatments/ 2012-04-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-to-sell-nutrition-unit-to-nestle/ 2012-04-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-to-acquire-ardea-biosciences-for-126bn/ 2012-04-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamylin-pharmaceuticals-to-look-for-buyer/ 2012-04-22T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglaxosmithkline-fails-in-bid-to-buy-human-genome-sciences/ 2012-04-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmichael-j-fox-foundation-to-sponsor-sanofis-trial-on-parkinsons-drug/ 2012-04-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsparkinsons-disease-map-helps-future-treatments/ 2012-04-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsabbotts-intestinal-gel-effective-in-advanced-parkinsons-patients/ 2012-04-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-supreme-court-rules-in-favour-of-caraco-in-generic-drug-fight/ 2012-04-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-zealand-firm-to-test-pig-cells-in-parkinsons-patients/ 2022-07-11T08:58:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-12/ 2023-04-12T06:33:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-enters-into-agreement-with-endocyte-over-cancer-drug-vintafolide/ 2012-04-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-scientists-show-support-for-tracking-parkinsons-study/ 2012-04-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspiramal-acquires-bayer-rd-portfolio/ 2021-10-21T11:09:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsworlds-biggest-parkinsons-study-coincides-with-parkinsons-awareness-week/ 2012-04-15T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjohnson-johnson-hit-with-fine-over-risperdal-advertising/ 2012-04-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsstem-cells-can-be-designed-to-kill-the-hiv-virus-study/ 2012-04-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newstakeda-to-acquire-url-pharma-for-800m/ 2012-04-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsabbott-gets-eu-approval-for-seventh-use-of-humira-drug/ 2012-04-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsamgen-acquires-kai-pharma-for-315m/ 2012-04-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrug-resistant-malaria-spreading-in-southeast-asia/ 2012-04-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsillumina-urges-shareholders-to-reject-roche-offer-following-iss-report/ 2012-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-delays-vivus-obesity-drug-decision-by-three-months/ 2012-04-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-fast-tracks-sanofis-zaltrap-drug-for-review-in-treating-colon-cancer/ 2012-04-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsabbott-unveils-positive-data-from-hcv-drug-trials/ 2012-04-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-amgen-to-develop-antibodies-for-inflammatory-disorders/ 2012-04-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsscripps-study-offers-new-hope-for-hcv-vaccine/ 2012-04-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsilumina-rejects-roches-takeover-offer/ 2012-04-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnice-rejects-eisais-halaven-for-breast-cancer-treatment/ 2012-04-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsoptimer-astellas-to-develop-drugs-for-cdi-superbug/ 2012-04-02T04:41:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurediminishing-vaccine-wastage-the-next-gen-of-temperature-controlled-packaging/ 2012-04-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsviiv-healthcare-hiv-drug-matches-mercks-rival/ 2012-04-01T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-increase-illumina-bid-by-15/ 2012-03-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-jersey-court-backs-astrazenecas-seroquel-xr-patent/ 2012-03-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-authorities-barred-from-importing-death-penalty-drug/ 2012-03-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsinovio-pharmaceuticals-multi-strain-flu-vaccine-gets-us-patent/ 2012-03-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsteva-launches-seroquel-generic/ 2012-03-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-extends-illumina-bid-for-a-second-time/ 2012-03-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayer-healthcare-tsinghua-university-expand-drug-discovery-agreement/ 2012-03-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsroche-slashes-india-cancer-drug-prices/ 2012-03-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-loses-plea-to-delay-market-entry-of-generic-seroquel/ 2012-03-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepackaging-the-problem-of-patient-adherence/ 2022-07-05T13:35:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newswatson-to-acquire-switzerlands-actavis/ 2012-03-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-court-rejects-astrazeneca-patent-extension-bid/ 2012-03-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsglaxosmithkline-to-invest-500m-in-uk-facilities/ 2012-03-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-backs-gsks-votrient-and-rejects-mercks-taltorvic/ 2012-03-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureuk-budget-2012-the-pharmaceutical-industry-reacts/ 2012-03-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureuk-budget-2012-boosting-pharmaceutical-research/ 2012-03-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-generic-copies-of-roches-boniva/ 2023-01-19T06:43:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsuk-praised-for-dementia-research/ 2012-03-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-11/ 2023-04-12T06:29:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsucb-pharma-oxford-university-to-develop-drugs-for-serious-diseases/ 2012-03-20T06:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newshealth-canada-to-speed-up-review-process-to-ease-drug-shortage/ 2012-03-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretrack-and-trace-europes-battle-against-falsified-drugs/ 2012-03-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsshire-announces-325m-acquisition-of-ferrokin/ 2012-03-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-eye-division-gains-rights-to-sell-ocriplasmin-in-europe/ 2012-03-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdenmarks-caremed-linked-to-fake-avastin-exports/ 2012-03-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-divests-healthcare-brands-to-omega/ 2012-03-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsteva-gets-first-approval-for-generic-lexapro/ 2012-03-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newspfizer-and-biocon-end-biosimilar-pact/ 2012-03-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnextgen-identifies-biomarker-to-track-changes-in-early-stage-dementia-patients/ 2022-07-28T10:07:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsindian-patent-office-issues-first-compulsory-license/ 2021-11-22T07:22:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-sues-fda-over-generic-copies-of-seroquel/ 2012-03-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjj-risperdal-settlement-rejected/ 2012-03-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsprostate-cancer-patients-await-nhs-scotland-decision-over-zytiga/ 2012-03-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseight-pharmaceutical-companies-sued-over-drug-coupon-use/ 2012-03-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsjj-cancer-drug-recommended-for-wider-use/ 2012-03-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbulk-buying-cause-of-canadian-drug-shortages/ 2012-03-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsdrug-shows-promise-in-advanced-alzheimers-patients/ 2012-03-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsranbaxy-launches-lipitor-generic-across-europe/ 2012-03-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-vertex-hepatitis-c-drugs-effective-in-hiv-patients/ 2012-03-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-continues-vaccine-movement-with-new-addition-to-agen-pact/ 2012-03-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsheart-drug-gets-european-approval/ 2012-03-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsarena-seeks-european-approval-for-lorcaserin/ 2012-03-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-daiichi-sankyo-sign-pact-to-supply-vaccines-in-japan/ 2012-03-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-pharmaceutical-companies-settle-medicaid-fraud-charges/ 2012-03-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newseu-commission-ends-antitrust-violation-by-astrazeneca-nycomed/ 2012-03-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsabbott-and-galapagos-collaborate-for-arthritis-drug/ 2012-02-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsparkinsons-drug-may-aid-brain-trauma-recovery/ 2012-02-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayer-issues-innovation-warning-despite-positive-results/ 2012-02-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-recommends-label-changes-to-statin-drugs/ 2012-02-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgsk-announces-rare-diseases-partnership-with-angiochem/ 2012-02-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfake-cancer-drug-contained-salt-starch-and-solvents/ 2012-02-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-announces-widespread-job-cuts/ 2012-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnhs-to-prescribe-roches-roactemra-drug/ 2012-02-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-ingelheim-forms-antibody-collaboration-with-xencor/ 2012-02-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsapproved-skin-cancer-drug-nearly-doubles-survival-times-study/ 2012-02-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-to-license-enanta-hepatitis-c-drug/ 2012-02-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newslanthio-pharma-grants-peptide-license-to-tarix/ 2012-02-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuresafe-simple-sustainable-pharma-packaging-trends/ 2012-02-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-thyroid-cancer-treatment-caprelsa-receives-approval/ 2012-02-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-two-suppliers-to-address-cancer-drug-shortages/ 2012-02-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-10/ 2023-04-12T06:34:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsgilead-suffers-hepatitis-c-drug-setback/ 2012-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsnew-drug-combination-destroys-pancreatic-cancer-cells/ 2012-02-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-could-launch-3bn-part-ipo/ 2012-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscritical-pharma-to-collaborate-with-university-of-nottingham/ 2012-02-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-pushes-into-brazilian-market-with-joint-venture/ 2021-11-22T12:41:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsworlds-first-trial-on-drug-delivery-microchip-proves-successful/ 2023-01-24T17:02:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newswyeth-seeks-960m-damages-from-sun-pharma/ 2012-02-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-profits-jump-amidst-warnings-of-generic-competition/ 2012-02-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuresmarter-faster-cheaper-three-ways-for-api-manufacturers-to-stay-ahead-of-the-game/ 2012-02-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsproposed-us-healthcare-budget-criticised/ 2012-02-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-rejects-glaskoroche-breast-cancer-drugs/ 2012-02-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-completes-25bn-acquisition-of-inhibitex/ 2012-02-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsobama-requests-fda-budget-increase/ 2012-02-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisai-leukaemia-treatment-dacogen-suffers-approval-setback/ 2012-02-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalzheimers-patients-call-for-off-label-drug-release/ 2012-02-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsformer-takeda-employee-charged-with-insider-trading/ 2012-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-drug-reverses-alzheimers-symptoms/ 2012-02-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgreece-confirms-state-pharmaceutical-spend/ 2012-02-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-rejects-amgens-request-to-expand-use-of-prostate-cancer-drug/ 2012-02-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsglaxosmithkline-to-expand-melbourne-site/ 2012-02-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbrain-cells-made-in-us-lab-open-doors-for-parkinsons-research/ 2012-02-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-health-ministers-in-denial-over-drug-shortages-says-aah/ 2012-02-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsucb-announces-robotic-drug-discovery-scientist-success/ 2012-02-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuremedical-cargo-theft-securing-the-supply-chain/ 2022-07-11T08:58:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstaiwan-vaccine-manufacturer-to-be-listed-on-stock-exchange/ 2012-02-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-serono-licenses-threshold-cancer-drug/ 2012-02-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnew-cost-cutting-medicaid-rule-could-save-us-billions/ 2012-02-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-receives-fda-approval-for-janumet/ 2012-02-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureless-is-more-why-rare-disease-funding-is-on-the-up/ 2012-02-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-job-cuts-more-severe-than-feared/ 2012-02-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgeneric-liptor-causes-pfizer-profit-slump/ 2012-02-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrumoured-job-cuts-at-astrazeneca/ 2012-01-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-skin-cancer-drug-erivedge-given-fda-nod/ 2012-01-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureahead-in-the-cloud-a-new-home-for-clinical-trial-data/ 2022-02-03T16:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-amylins-diabetes-drug-bydureon/ 2012-01-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspakistan-supreme-court-orders-release-of-pharma-owners/ 2012-01-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgen-to-acquire-micromet/ 2012-01-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbig-pharma-to-collaborate-to-combat-neglected-diseases/ 2022-12-20T10:21:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsxenoport-accuses-gsk-of-contract-breach/ 2012-01-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsindian-agencies-seize-hospital-records-after-fake-drugs-cause-cardiac-patient-deaths/ 2012-01-26T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-net-profit-falls-47/ 2012-01-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshikma-and-ergomed-announce-clinical-trial-partnership/ 2012-01-25T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-to-establish-us-diabetes-research-centre/ 2012-01-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-hostile-bid-for-illumina-full-and-fair/ 2012-01-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-9/ 2023-04-12T06:34:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-begins-final-trial-on-alzheimers-drug/ 2012-01-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newswatson-to-acquire-ascent-pharmahealth/ 2012-01-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuregoing-with-the-flow-continuous-manufacturing/ 2012-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscannabis-based-cancer-pain-drug-could-hit-us-shelves/ 2012-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-settles-vioxx-litigation-in-canada/ 2012-01-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbtg-receives-us-voraxaze-approval/ 2012-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-bristol-myers-squibb-diabetes-drug-rejected-by-fda/ 2012-01-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjobs-lost-as-takeda-restructures/ 2012-01-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsantidepressants-cause-three-times-more-falls-in-people-with-dementia-study/ 2012-01-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssingapore-sees-rise-in-pharmaceutical-shipments/ 2012-01-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstotally-drug-resistant-tb-found-in-mumbai/ 2012-01-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-to-cut-nearly-2000-us-pharma-jobs/ 2012-01-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslloydspharmacy-to-offer-smart-drugs-packages/ 2012-01-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-calls-for-strictest-warning-on-drug-linked-to-brain-infection/ 2012-01-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureinvestigator-relations-road-to-success-for-clinical-trials/ 2022-07-11T08:58:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-to-enter-into-european-evidence-collaboration/ 2012-01-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-user-fee-programmes-to-speed-up-drug-approvals/ 2012-01-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-to-shun-mega-mergers/ 2012-01-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-looking-at-asian-expansion/ 2012-01-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslarge-acquisitions-out-research-alliances-in-says-pfizer-ceo/ 2012-01-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-responds-to-argentinian-court-ruling-over-controversial-vaccine-trials/ 2012-01-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslx4211-combination-therapy-found-to-treat-type-2-diabetes/ 2023-05-24T04:07:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-fined-over-controversial-vaccine-trials-on-argentinean-babies/ 2022-07-11T08:58:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstexas-prosecutors-seek-more-than-1bn-from-johnson-johnson/ 2012-01-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaeras-and-china-biotec-group-to-develop-new-tb-vaccines/ 2012-01-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-unveils-25bn-plans-to-acquire-inhibitex/ 2012-01-09T06:02:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsinhaled-parkinsons-drug-shows-positive-results/ 2012-01-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-to-pursue-development-of-targacepts-alzheimers-candidate/ 2012-01-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshospira-facing-pressure-over-execution-drug/ 2012-01-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsisis-pharma-and-biogen-idec-sign-drug-development-deal/ 2012-01-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshepatitis-c-vaccine-trial-shows-positive-results/ 2012-01-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-named-best-big-drug-company-of-2011/ 2012-01-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-and-johnson-johnson-seek-new-approval-for-xarelto/ 2012-01-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmozambique-to-produce-its-own-antiretrovirals/ 2012-01-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsactavis-to-launch-new-pain-drug-in-the-us/ 2011-12-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsglaxosmithkline-shears-off-over-the-counter-brands/ 2011-12-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-boosts-oncology-pipeline-with-intellikine-acquisition/ 2011-12-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-to-review-pfizers-experimental-arthritis-drug/ 2011-12-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-awards-catalyst-cocaine-dependency-drug-fast-track-status/ 2023-01-23T13:31:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-hit-by-further-drug-development-disappointment/ 2011-12-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamgen-and-watson-link-up-to-develop-cancer-drugs/ 2011-12-19T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurefuture-oncology-the-path-to-personalised-medicine/ 2011-12-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazenecas-faslodex-given-final-snub-by-nice/ 2011-12-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstwo-pharma-employees-killed-in-india-reactor-blast/ 2011-12-18T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureprefilled-syringes-getting-to-the-point/ 2011-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-announces-huntingtons-pact-with-university-of-dundee/ 2023-05-09T07:00:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsus-cracks-down-on-prescription-drug-delays/ 2011-12-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-cancer-treatment-costs-to-spiral-by-2021/ 2011-12-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-compounds-now-available-to-uk-researchers/ 2011-12-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-subsidiary-charged-with-fraud/ 2011-12-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsms-drug-safety-questioned-after-patient-dies/ 2011-12-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-8/ 2023-04-12T06:38:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsglenmark-to-seek-napo-arbitration/ 2011-12-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvaximm-to-launch-first-oral-cancer-vaccine-study/ 2011-12-12T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfuriex-shares-fall-as-it-halts-cholesterol-drug-development/ 2011-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbreast-cancer-patients-quit-drugs-due-to-severe-side-effects-study-finds/ 2011-12-11T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuresnapshot-can-increased-collaboration-between-big-pharma-and-academia-counter-rd-patent-and-approval-issues-in-the-industry/ 2011-12-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmajor-drug-firms-come-together-to-launch-huge-pharma-database/ 2011-12-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-slashes-us-sales-team/ 2011-12-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureenhancing-bioavailability/ 2011-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-to-establish-china-research-headquarters/ 2011-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshhe-overrules-fda-decision-on-plan-b-pill/ 2011-12-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-unveils-global-vaccine-business-plans/ 2011-12-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-hopeful-that-fda-will-lift-age-restriction-on-plan-b-pill/ 2011-12-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseisai-opens-us-cancer-facility/ 2011-12-05T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-to-enter-lipitor-generic-market/ 2011-12-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-acquires-excaliard-pharmaceuticals/ 2011-12-04T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrussian-pharmaceutical-industry-questions-pricing-strategy/ 2011-12-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-discontinues-generic-deep-vein-thrombosis-drug/ 2023-02-10T12:40:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsranbaxy-gets-nod-to-sell-generic-lipitor-in-the-us/ 2011-11-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslatent-tuberculosis-vaccine-enters-clinical-testing/ 2011-11-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featureno-risk-no-reward-outsourcing-the-supply-chain/ 2022-07-11T09:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-to-end-animal-testing/ 2011-11-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-rejects-novartis-eye-drug-for-diabetic-patients/ 2011-11-29T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshospital-treated-infections-market-to-exceed-4bn-by-2020/ 2011-11-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssclerosis-drug-could-slow-eye-cancer-growth/ 2011-11-28T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-intermezzo-sublingual-tablet-for-insomnia/ 2011-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssummit-smt-c1100-secures-fda-orphan-drug-status/ 2011-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-submits-nva237-for-japanese-approval/ 2011-11-27T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsthree-pharma-plant-workers-seriously-injured-in-reactor-explosion/ 2023-03-03T11:30:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-to-buy-excaliard-pharmaceuticals/ 2011-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsprana-cleared-to-commence-alzheimers-drug-trial/ 2011-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsmerck-to-send-flood-hit-thailand-water-test-kits/ 2011-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-switches-hpv-vaccine-supplier/ 2011-11-24T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscelldex-presents-survival-data-from-glioblastoma-drug-trial/ 2011-11-24T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsportola-secures-financing-for-phase-iii-betrixaban-study/ 2011-11-24T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-to-sell-lipitor-at-generic-prices/ 2011-11-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaids-drug-assistance-program-slams-merck-for-unethical-behaviour/ 2011-11-23T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-clearance-for-tonix-to-begin-tnx-102-study/ 2011-11-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsregeneron-eylea-injection-wins-fda-nod/ 2011-11-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-settles-vioxx-lawsuit-in-the-us/ 2011-11-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsindian-supreme-court-slams-drug-prices/ 2011-11-22T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsimprime-pgg-combination-therapy-found-effective-against-cancer/ 2011-11-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-accepts-nda-filing-for-chelsea-northera-drug/ 2011-11-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscancer-research-uk-begins-stratified-medicine-programme-enrolment/ 2011-11-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-sciences-to-acquire-pharmasset-for-11bn/ 2011-11-21T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretake-a-load-off-the-age-of-cloud-computing/ 2022-02-03T16:44:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvirtify-adds-kallik-technology-to-labelling-solution/ 2011-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsreport-highlights-rising-use-of-mental-health-medications-in-us/ 2011-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-revokes-avastin-approval/ 2011-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsimproved-access-to-drugs-reduces-aids-related-deaths/ 2011-11-20T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspalifosfamide-combination-therapy-found-effective-against-sclc/ 2023-01-04T11:07:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-tibotec-to-develop-hiv-medication/ 2011-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbreast-cancer-organisation-awards-research-grants-worth-2m/ 2011-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstesco-pharmacies-join-fight-against-dementia/ 2011-11-17T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslallemand-and-gm-pharmaceuticals-launch-ismigen-in-georgia/ 2011-11-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsincyte-corps-gets-first-approval-for-myelofibrosis-drug/ 2021-10-29T05:21:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-drug-shortages-limited-to-generic-injectables/ 2011-11-16T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-intelgenx-anti-depressant/ 2011-11-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-and-pfizer-report-apixaban-trial-results/ 2011-11-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featuretaking-aim-with-nanotechnology/ 2011-11-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbayer-predicts-asia-sales-of-11bn-by-2015/ 2011-11-15T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-praised-as-colombia-eliminates-river-blindness/ 2023-02-06T07:09:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-7/ 2023-04-12T06:34:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-international-acquires-baxa/ 2011-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-drug-status-to-santen-sirolimus-drug/ 2011-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-cord-blood-therapy/ 2011-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgeron-announces-shift-from-stem-cell-research-to-oncology/ 2011-11-14T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsanacor-completes-patient-enrollment-for-an2690-drug-study/ 2023-05-15T03:51:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalkermes-vivitrol-treats-opioid-dependence-in-study/ 2011-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsotsuka-signs-psychiatric-drug-pact-with-lundbeck/ 2011-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuae-cuts-prices-of-115-drugs/ 2011-11-13T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssalix-to-acquire-oceana-operating-subsidiary/ 2011-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsopexa-tovaxin-drug-receives-fda-fast-track-designation/ 2011-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-hit-by-double-fda-rejection/ 2011-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-named-praised-for-flu-pandemic-preparedness/ 2011-11-10T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsduocort-plenadren-drug-receives-european-approval/ 2011-11-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsucb-reports-rapid-1-post-hoc-data-of-cimzia-drug/ 2011-11-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsamylin-and-lilly-to-dissolve-diabetes-agreement/ 2011-11-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmalaria-blood-entry-route-discovered-by-uk-scientists/ 2011-11-09T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurea-new-era-of-drug-safety-european-pharmacovigilance/ 2011-11-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbott-announces-results-of-humira-trials/ 2011-11-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsacadia-meiji-seika-pharma-partner-to-advance-am-831-drug-study/ 2021-12-02T06:50:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-cuts-1000-jobs-across-us-and-europe/ 2011-11-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroches-skin-cancer-drug-granted-priority-review-by-fda/ 2011-11-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaslan-bristol-myers-partner-for-cancer-drug-development/ 2011-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-submits-maa-for-lyxumia-drug/ 2011-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-to-retain-650-jobs-at-uk-rd-facility/ 2011-11-07T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsligand-captisol-enabled-melphalan-meets-trial-goals/ 2011-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvertexs-kalydeco-shows-efficacy-against-cystic-fibrosis/ 2011-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-claims-fastest-drug-approvals/ 2011-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-bayers-anti-clotting-drug/ 2011-11-06T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsexelixis-to-commence-prostate-cancer-drug-trial/ 2011-11-04T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsdomainex-wins-grant-to-develop-cancer-drug/ 2011-11-04T03:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-reacts-to-third-quarter-results-delays-laquinimod/ 2011-11-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-drug-approval-rates-higher-than-ever/ 2011-11-03T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-clears-pacira-post-surgical-pain-management-therapy/ 2021-11-22T12:39:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalios-biopharma-versitech-partner-for-influenza-therapy/ 2011-11-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsindia-to-extend-pharmaceutical-price-control/ 2011-11-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsglaxosmithkline-settles-us-drug-dispute-for-3bn/ 2011-11-02T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-acquires-icagen/ 2011-11-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-clears-vegenics-vgx-100-drug-trial/ 2022-07-11T09:04:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-to-top-sales-league-ousting-pfizer/ 2011-11-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssmall-business-representative-opposes-express-scrips-medco-merger/ 2011-11-01T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-approves-mylan-pain-drug/ 2011-10-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-gilead-join-forces-to-develop-hiv-drug/ 2011-10-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmerck-net-income-rise-on-key-drug-performance/ 2011-10-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsobama-orders-fda-to-tackle-drug-shortage/ 2011-10-31T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbionovo-commences-menerba-drug-phase-3-trial/ 2011-10-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newskempharm-to-develop-new-pain-therapy/ 2011-10-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiotie-and-merck-turn-their-backs-on-newron/ 2011-10-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-reports-strong-revenue-rise/ 2011-10-30T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbasilea-completes-bal30072-antibiotic-trial/ 2011-10-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsatox-bio-receives-orphan-drug-designation-for-ab103/ 2011-10-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscrestor-drives-astrazeneca-financials/ 2011-10-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnice-approves-astrazeneca-acute-coronary-syndromes-drug/ 2011-10-27T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsencap-partners-lena-to-develop-new-drug-delivery-technology/ 2011-10-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-and-globeimmune-join-forces-to-develop-hepatitis-b-vaccine/ 2011-10-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslilly-to-withdraw-sepsis-drug-xigris/ 2011-10-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiogen-idec-ms-drug-shows-positive-results/ 2011-10-26T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsxencor-launches-phase-i-xmab5871-study/ 2011-10-26T02:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalemtuzumab-found-superior-to-standard-ms-treatment/ 2011-10-26T02:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurekeeping-your-cool-pharmaceutical-supply-chain-management-in-remote-areas/ 2023-05-12T11:32:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-and-dr-reddys-pounce-with-zyprexa-generics/ 2011-10-25T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-health-committee-recommends-mercks-hpv-vaccine-for-boys/ 2023-01-04T11:33:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsallon-completes-patient-enrolment-for-progressive-supranuclear-palsy-drug-trial/ 2022-07-11T09:04:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsus-fda-approves-sagent-bupivacaine-hydrochloride-injection/ 2011-10-25T02:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaustralian-regulator-questions-pfizer-patient-support-programme/ 2011-10-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstransgene-vaccine-trial-gives-hope-to-lung-cancer-patients/ 2011-10-24T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnatco-joins-mabxience-to-manufacture-mab-finished-dose-formulations/ 2011-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstetraphase-wins-respiratory-antibiotic-contract/ 2011-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslilly-earnings-fall-despite-sales-increase/ 2011-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseu-regulator-launches-antitrust-probe-over-suspected-painkiller-delay/ 2011-10-23T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsservier-partners-miragen-to-develop-microrna-targeting-drugs/ 2011-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmeloxicam-depot-injection-proven-to-treat-pain-and-inflammation/ 2011-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newseuropean-court-of-justice-rules-against-stem-cell-patents/ 2011-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssun-must-double-taro-offer/ 2011-10-20T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurecarpooling-for-cargo/ 2011-10-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-begins-type-2-diabetes-drug-phase-3-trial/ 2011-10-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsoxford-biomedica-gets-fda-ind-approval-for-ushstat-therapy/ 2011-10-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsabbott-to-spin-off-pharmaceutical-business/ 2011-10-19T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-6/ 2023-04-12T06:38:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-pharmaceutical-acquires-cephalon/ 2011-10-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgalenica-submits-injectafer-nda-to-fda/ 2011-10-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-to-acquire-anadys/ 2011-10-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newschemocentryx-commences-ccx168-drug-trial/ 2022-07-11T09:04:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjj-defies-generics-by-posting-sales-increase/ 2011-10-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgsk-malaria-vaccine-trial-brings-hope-to-african-children/ 2011-10-18T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspozen-reports-long-term-safety-study-results-of-pa32540/ 2011-10-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newskissei-pharmaceutical-to-support-mn-221-development-programme/ 2021-11-22T07:38:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-to-acquire-hepatitis-c-specialist-anadys/ 2011-10-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newswide-spread-treatment-distribution-cuts-malaria-by-20/ 2011-10-17T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnih-funds-ucsf-to-develop-antimalarial-drugs/ 2011-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsintellikine-commences-ink1117-drug-trial/ 2011-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-acquires-hcv-manufacturer/ 2011-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/newsbayer-and-onyx-restructure-oncology-collaboration/ 2011-10-16T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnac-launches-new-bordetella-pertussis-toxin/ 2023-01-04T12:24:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsglycomimetics-pfizer-to-further-develop-gmi-1070-drug/ 2011-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-complete-cephalon-acquisition/ 2011-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbristol-myers-squibb-skin-cancer-drug-too-costly-for-nhs/ 2011-10-13T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsroche-alzheimers-drug-found-to-safely-remove-amyloid-plaques/ 2011-10-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsaimspro-proven-effective-to-treat-late-stage-systemic-sclerosis/ 2023-02-23T05:41:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurethe-sustainable-supply-chain/ 2022-07-11T09:04:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssanofi-unit-genzyme-inaugurates-waterford-biotechnology-expansion/ 2011-10-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsonyx-to-retain-nexavar-rights/ 2011-10-12T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbit225-drug-found-effective-against-hepatitis-c-virus/ 2011-10-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspaladin-labs-acquires-labopharm/ 2011-10-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsindia-to-tighten-scrutiny-over-foreign-pharmaceutical-takeovers/ 2011-10-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsearly-treatment-linked-to-life-expectancy-rise-in-hiv-patients/ 2011-10-11T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteriflunomide-shows-efficacy-against-multiple-sclerosis/ 2011-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-clears-mercks-type-2-diabetes-medication/ 2011-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-wins-battle-over-best-selling-lipitor/ 2011-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsteva-told-to-divest-assets-by-us-federal-trade-commission/ 2011-10-10T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbiosante-completes-libigel-efficacy-trials/ 2011-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscytrx-reports-preliminary-efficacy-results-of-bafetinib/ 2011-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-to-cut-400-us-jobs/ 2011-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmercks-treatment-for-cholesterol-and-diabetes-approved-by-fda/ 2011-10-09T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newssantaris-to-report-miravirsen-drug-trial-results/ 2011-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsauxilium-doses-first-patient-in-dupuytrens-contracture-multicord-study/ 2011-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsgilead-granted-ncinis-rights-by-boehringer/ 2011-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsfda-awards-multi-million-dollar-grant-to-improve-us-drug-manufacturing/ 2011-10-06T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsalkermes-commences-opioid-induced-constipation-drug-trial/ 2023-05-31T06:22:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovavax-rsv-vaccine-phase-1-trial-shows-efficacy/ 2011-10-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-to-launch-saudi-manufacturing-plant/ 2011-10-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazenca-settles-second-seroquel-dispute-in-two-weeks/ 2011-10-05T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/featurethe-patent-cliff-rise-of-the-generics/ 2011-10-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsvfend-combination-therapy-shows-positive-results-pfizer-study/ 2011-10-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbaxter-seeks-european-approval-for-hyq/ 2011-10-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsuk-to-provide-better-access-to-rare-disease-drugs/ 2011-10-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-unit-acquires-tremelimumab-rights-from-pfizer/ 2011-10-04T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newshorizon-submits-nda-for-ra-drug/ 2011-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newscog-apeiron-to-jointly-conduct-apn301-trial/ 2023-01-24T16:52:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newstakeda-closes-nycomed-acquisition/ 2011-10-03T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newslannett-loxapine-capsules-gets-fda-approval/ 2011-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsrexahn-completes-patient-enrollment-in-cancer-drug-trial/ 2011-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newspfizer-takes-campaign-against-counterfeiters-to-youtube/ 2011-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbeta-blockers-could-bring-hope-to-breast-cancer-patients/ 2011-10-02T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsmicrodose-doses-first-patient-in-respiratory-syncytial-virus-drug-trial/ 2011-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsbl-1020-effectively-treats-schizophrenia-biolinerx-study/ 2011-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsjohnson-and-johnson-to-acquire-mercks-share-of-consumer-pharmaceuticals/ 2011-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-settles-seroquel-xr-dispute/ 2011-09-29T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovartis-reports-positive-bolero-2-trial-results/ 2011-09-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsastrazeneca-faslodex-wins-japanese-regulatory-approval/ 2011-09-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-looks-to-launch-lantus-rivals-in-europe/ 2011-09-28T17:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newsflorida-court-issues-injunction-against-hill-dermaceuticals/ 2011-09-28T17:30:00+00:00 daily 0.2